---

---

symbols : Gsk   

save search

---

Global Myasthenia Gravis Treatment Market Report 2023 - Opportunities in Tailored Treatment Approaches, Biologics and Immunotherapies and Patient-Centric Care
Published: 2023-12-06 (Crawled : 18:00) - prnewswire.com
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 0.03% | O: 0.03% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M |

Health Technology

| -0.6% | O: -0.6% H: 0.0% C: 0.0%
report treatment care global market

---

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| 0.17% | O: 0.17% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 0.03% | O: 0.03% H: 0.0% C: 0.0%
LLY 6 d | $588.27 -0.17% -0.1% 2.1M |

Health Technology

| 0.99% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M |

Health Technology

| 0.26% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $18.72 -2.19% -2.24% 1.1M |

Health Technology

| -0.22% | O: -0.22% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M |

Health Technology

| 0.46% | O: 0.46% H: 0.0% C: 0.0%
disease parkinson's revenue research therapeutics market

---

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| 0.17% | O: 0.17% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 0.03% | O: 0.03% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M |

Health Technology

| 0.26% | O: 0.26% H: 0.0% C: 0.0%
AZN | $63.5 -0.14% -0.14% 6.2M |

Health Technology

| 0.77% | O: 0.77% H: 0.0% C: 0.0%
GOOGL | $136.94 5.32% 5.05% 55M |

Technology Services

| 1.97% | O: 1.97% H: 0.0% C: 0.0%
GOOG | $138.415 5.32% 5.05% 38M |

Technology Services

| 1.97% | O: 1.97% H: 0.0% C: 0.0%
tube companies abbvie cancer pharmaceuticals therapeutics market

---

RNA- Based Therapeutic Market worth $29.41 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2023-12-05 (Crawled : 15:00) - prnewswire.com
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| -0.63% | O: -0.85% H: 0.39% C: 0.19%
SNY | News | $46.06 0.17% 0.17% 1.9M |

Health Technology

| -1.1% | O: -0.5% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M |

Health Technology

| -1.47% | O: -0.88% H: 0.21% C: -1.05%
report market

---

Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| -0.97% | O: -1.14% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| -0.63% | O: -0.85% H: 0.39% C: 0.19%
ABBV | News | $147.97 1.09% 0.05% 7.2M |

Health Technology

| 1.08% | O: 0.51% H: 0.68% C: 0.32%
SNY | News | $46.06 0.17% 0.17% 1.9M |

Health Technology

| -1.1% | O: -0.5% H: 0.0% C: 0.0%
GLMD | $0.3988 0.96% 0.95% 580K |

Health Technology

| 7.22% | O: 8.33% H: 2.44% C: -1.03%
AMGN S | $271.33 0.74% 0.73% 2M |

Health Technology

| -0.08% | O: 0.29% H: 0.05% C: -0.37%
america market

---

Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $0.579 9.45% 8.64% 240K |

Professional, Scientific, and T...

| -2.07% | O: -2.05% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 1.99% | O: -0.51% H: 0.96% C: 0.54%
GERN | $2.095 5.28% 5.01% 5.3M |

Health Technology

| 1.83% | O: -1.05% H: 2.65% C: 1.06%
corporation

---

Gonorrhea Therapeutics Market to grow by USD 506.68 million from 2022 to 2027; North America accounts for 39% of market growth - Technavio
Published: 2023-11-21 (Crawled : 20:00) - prnewswire.com
GLAXF | $17.76 2.25% 700 |

Health Technology

| -1.39% | O: -3.23% H: 0.0% C: -0.35%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 2.71% | O: -0.23% H: 0.2% C: -0.28%
america therapeutics growth market

---

Ewing's Sarcoma Treatment Market to grow by USD 205.09 million from 2024-2028; North America to account for 48% of market growth - Technavio
Published: 2023-11-20 (Crawled : 19:00) - prnewswire.com
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| 2.34% | O: 0.91% H: 0.6% C: 0.27%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 3.5% | O: 0.51% H: 0.77% C: 0.26%
BAX | $36.53 1.67% 0.0% 4M |

Health Technology

| 2.92% | O: 0.39% H: 0.2% C: -0.17%
america treatment growth market

---

Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16 (Crawled : 22:00) - prnewswire.com
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| 3.91% | O: 1.19% H: 0.0% C: 0.0%
JNJ | News | $155.4 -0.78% -0.02% 6.4M |

Health Technology

| 6.03% | O: 0.78% H: 0.0% C: 0.0%
ABT | News | $104.05 -0.85% -0.14% 5.2M |

Health Technology

| 6.74% | O: 2.58% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M |

Health Technology

| 0.46% | O: 1.42% H: 0.0% C: 0.0%
rare disease cell eye market

---

Digital Dose Inhaler Market Set for Remarkable Growth, Estimated at $104.3 Billion by 2033
Published: 2023-11-16 (Crawled : 01:00) - prnewswire.com
GLAXF | $17.76 2.25% 700 |

Health Technology

| 3.87% | O: 0.59% H: 0.0% C: 0.0%
AZNCF | $125.75 8.15% 2.6K |

Health Technology

| 2.67% | O: -2.16% H: 4.44% C: 2.2%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 5.43% | O: -0.41% H: 0.0% C: 0.0%
MMM | News A | $103.28 0.48% 0.22% 2.3M |

Producer Manufacturing

| 6.87% | O: 0.25% H: 0.0% C: 0.0%
AZN | $63.5 -0.14% -0.14% 6.2M |

Health Technology

| 1.48% | O: -0.22% H: 0.71% C: 0.6%
set market

---

CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-11-14 (Crawled : 12:00) - curevac.com
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 5.12% | O: 0.23% H: 0.0% C: 0.0%
CVAC | $5.53 1.1% 1.08% 600K |

Health Technology

| 1.59% | O: 8.15% H: 0.0% C: 0.0%

---

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-13 (Crawled : 22:00) - globenewswire.com
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 5.12% | O: 0.23% H: 0.0% C: 0.0%
SCYX | $1.7 1.19% 1.18% 110K |

Health Technology

| 1.17% | O: 3.79% H: 0.0% C: 0.0%
update financial results

---

Adult Vitamin Gummies Market to grow by USD 2.75 billion from 2023-2028; North America to account for 41% of market growth - Technavio
Published: 2023-11-10 (Crawled : 23:00) - prnewswire.com
UNLYF | News | $47.42 6.92% 490 |

Consumer Non-Durables

| Email alert Add to watchlist
UL | News | $47.94 0.36% -0.07% 2.1M |

Consumer Non-Durables

| Email alert Add to watchlist
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| Email alert Add to watchlist
GLAXF | $17.76 2.25% 700 |

Health Technology

| Email alert Add to watchlist
america growth market

---

23andMe Reports Second Quarter Fiscal 2024 Financial Results
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| Email alert Add to watchlist
financial results

---

Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $17.76 2.25% 700 |

Health Technology

| 2.61% | O: 1.91% H: 0.0% C: 0.0%
VERV 6 d | $12.89 3.2% 3.1% 1.4M |

Professional, Scientific, and T...

| -29.56% | O: 14.28% H: 0.64% C: -10.76%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 3.9% | O: 0.47% H: 0.46% C: -0.23%
MRNA | $79.92 -0.84% -0.85% 3.5M |

Health Technology

| 8.39% | O: 1.55% H: 0.0% C: 0.0%
CVAC | $5.53 1.1% 1.08% 600K |

Health Technology

| -1.45% | O: 1.09% H: 1.08% C: -1.44%
BNTX | $101.94 0.59% 0.59% 810K |

Health Technology

| 0.44% | O: 4.26% H: 0.08% C: -2.81%
ARCT | $23.99 2.35% 2.29% 240K |

Health Technology

| 23.11% | O: 4.66% H: 0.79% C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market

---

COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
VTRS | $9.76 0.72% 0.72% 6.5M |

Health Technology

| -1.4% | O: -0.54% H: 0.33% C: -0.98%
TEVA | $9.97 1.42% 0.0% 5.6M |

Health Technology

| 11.38% | O: 0.0% H: 0.0% C: 0.0%
TAK | $14.08 1.0% 0.0% 1.4M |

Health Technology

| 1.9% | O: 0.44% H: 0.22% C: 0.07%
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| 4.46% | O: 0.38% H: 0.18% C: 0.16%
JNJ | News | $155.4 -0.78% -0.02% 6.4M |

Health Technology

| 4.52% | O: 0.18% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 4.46% | O: 0.53% H: 0.0% C: 0.0%
ABT | News | $104.05 -0.85% -0.14% 5.2M |

Health Technology

| 9.4% | O: -0.42% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M |

Health Technology

| 1.3% | O: -1.32% H: 0.0% C: 0.0%
covid-19

---

NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
ENDPQ | $0.0013 669.23% 150K |

n/a

| -72.86% | O: 0.0% H: 0.0% C: -25.71%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 6.35% | O: 1.43% H: 0.82% C: 0.38%
NRBO | $0.509 -0.12% -0.12% 110K |

Health Technology

| 18.9% | O: 2.1% H: 0.0% C: 0.0%
pharmaceuticals

---

CureVac meldet Fortschritte in klinischen Phase-2-Entwicklungsprogrammen für COVID-19 und die saisonale Grippe in Zusammenarbeit mit GSK
Published: 2023-11-01 (Crawled : 13:00) - curevac.com
GLAXF | $17.76 2.25% 700 |

Health Technology

| -1.61% | O: -1.62% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 2.68% | O: -3.0% H: 0.0% C: 0.0%
CVAC | $5.53 1.1% 1.08% 600K |

Health Technology

| 4.03% | O: 1.92% H: 3.95% C: -1.32%
covid-19 phase 2

---

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | $17.76 2.25% 700 |

Health Technology

| -1.61% | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $92.11 3.42% 640 |

Health Technology

| 6.53% | O: 1.94% H: 2.55% C: 2.55%
NVO | $96.81 -0.8% 0.25% 3.4M |

Health Technology

| 3.3% | O: 0.92% H: 0.0% C: 0.0%
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M |

Health Technology

| 4.2% | O: 0.19% H: 0.7% C: 0.57%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 2.68% | O: -3.0% H: 0.0% C: 0.0%
LLY 6 d | $588.27 -0.17% -0.1% 2.1M |

Health Technology

| 3.58% | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M |

Health Technology

| 1.56% | O: 0.18% H: 0.0% C: 0.0%
expected reach global dna medical technology market

---

Premature Ejaculation (PE) Treatment Market size to grow by USD 1.45 billion from 2023-2028| A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Ltd., and more among the key companies in the market - Technavio
Published: 2023-10-31 (Crawled : 22:00) - prnewswire.com
GLAXF | $17.76 2.25% 700 |

Health Technology

| -1.61% | O: -1.62% H: 0.0% C: 0.0%
GSK | $36.0 -0.47% 0.06% 2.2M |

Health Technology

| 2.68% | O: -3.0% H: 0.0% C: 0.0%
VERU | $1.155 4.05% 3.9% 990K |

Health Technology

| 6.88% | O: -1.68% H: 2.25% C: -6.4%
companies treatment pharmaceuticals market

---

Gainers vs Losers

69%

31%

Top 10 Gainers

SLDB | News M | $5.89 72.22% 41.94% 12M |

Health Technology

SVFD | News | $3.09 43.72% 30.42% 64M |

FTEL | $2.04 43.66% 30.39% 110K |

HPCO 4 | $0.4824 41.92% 29.54% 28M |

ALGS | News | $0.6475 -5.06% 26.67% 2.1M |

Health Technology

GTHX | $3.16 30.58% 23.42% 10M |

Health Technology

KEQU | $22.5 27.62% 21.64% 24K |

Producer Manufacturing

GSIT | $3.09 27.16% 21.36% 2.2M |

Electronic Technology

SSKN P | $0.628 25.6% 20.38% 210K |

Health Technology

GLUE | $3.66 22.82% 18.58% 510K |

Professional, Scientific, and T...

---

Your saved searches

---